Biotech
Regent Pacific's Deep Longevity Announces Partnership with LifeHub & LifeClinic in Hong Kong
2021-05-20 12:00
8913
HONG KONG, May 20, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK)'s wholly owned Deep Longevity, Inc, a leading provider of deep biomarkers of aging and longevity is pleased to announce a c...
Kintor Announced (1) FDA Has Greenlighted Proxalutamide's Phase III Study for Hospitalized Male and Female COVID-19 Patients to Be Conducted; and (2) Inclusion of Female Outpatients in Proxalutamide's Phase III Study for Mild to Moderate COVID-19
2021-05-20 09:47
8598
SUZHOU, China, May 19, 2021 /PRNewswire/ -- On May 18, Kintor Pharmaceutical Limited (HKEX.9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the U.S. Food and Drug Administration (FDA) has greenlighted proxalutamide's ph...
ASCO 2021 | Ascentage Pharma to Announce Updated Data of Lisaftoclax (APG-2575) Demonstrating an ORR of Around 80% and Therapeutic Potential in Patients with R/R CLL/SLL in Oral Presentation
2021-05-20 08:44
4330
SUZHOU, China and ROCKVILLE, Md., May 20, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that an abstract reporting on...
ASCO 2021 | Ascentage Pharma to Announce Updated Results Demonstrating Clinical Potential of Alrizomadlin (APG-115) Plus Pembrolizumab in Patients with Advanced Solid Tumors that Had Failed Immunotherapies in Oral Presentation
2021-05-20 08:17
4605
SUZHOU, China and ROCKVILLE, Md., May 20, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that abstracts reporting on t...
Duality Biologics Completed $90 Million Series B Financing
2021-05-20 08:00
1443
PRINCETON, N.J. and SHANGHAI and SUZHOU, China, May 19, 2021 /PRNewswire/ -- Duality Biologics (DualityBio or Company), an innovative biotech company, announced the completion of$90 million series B financing today. This round of financing was led by Lilly Asia Ventures (LAV) and jointly invested...
I-Mab Presents Phase 1 Data on Highly Differentiated CD73 Antibody Uliledlimab at ASCO 2021
2021-05-20 06:00
8171
* Uliledlimab is a highly differentiated CD73 antibody with a unique epitope that confers pharmacological advantages * Data from U.S. phase 1 dose escalation trial demonstrates favorable safety and tolerability with no dose-limiting toxicities; preliminary clinical activity of uliledlimab has...
Gracell Biotechnologies to Present Updated Results of GC012F FasTCAR-enabled BCMA/CD19 Dual-targeting CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma at ASCO 2021 and EHA 2021
2021-05-20 05:15
8359
SUZHOU, China and PALO ALTO, Calif., May 19, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, is presenting updated ...
ThinkCyte Secures $26 million in Series B Financing
2021-05-19 22:00
1928
TOKYO, May 19, 2021 /PRNewswire/ -- ThinkCyte, Inc., a company focusing on the development of novel cell therapy, drug discovery and diagnostic platforms, announced today the completion of a $26 million (JPY 2.85 billion) Series B financing, led by SPARX Group with participation from Sysmex Corpo...
Legend Capital Announces Successful Closing of Healthcare Continuation Fund
2021-05-19 09:01
1627
BEIJING, May 18, 2021 /PRNewswire/ -- Legend Capital announced today that the firm has closed LC Healthcare Continued Fund I, L.P., having raised US$270 million for a secondary transaction that involves healthcare portfolios of two older vintage funds. The fund provides liquidity and helped to en...
Firmenich Enters Strategic Partnership with Essential Labs, LLC, a Leading B2B E-Commerce Supplier of Fragrance Solutions
2021-05-18 23:00
1876
GENEVA, May 18, 2021 /PRNewswire/ -- Firmenich, the world's largest privately-owned fragrance and taste company, has entered into a strategic partnership with Essential Labs, LLC, a leading B2B supplier of fragrance solutions supporting entrepreneurial, independent businesses in the premium home...
Firmenich Enters Strategic Partnership with Essential Labs, LLC, a Leading B2B E-Commerce Supplier of Fragrance Solutions
2021-05-18 23:00
2038
GENEVA, May 18, 2021 /PRNewswire/ -- Firmenich, the world's largest privately-owned fragrance and taste company, has entered into a strategic partnership with Essential Labs, LLC, a leading B2B supplier of fragrance solutions supporting entrepreneurial, independent businesses in the premium home...
Dinova and Metronom Health, an innovative glucose monitoring company, announces launch of a joint venture in China
2021-05-18 23:00
2028
HANGZHOU, China, May 18, 2021 /PRNewswire/ -- Dinova Medtech, a highly specialized medical device innovation hub, with Ascendum Capital, a new healthcare-focused investment platform, and Metronom Health, an innovative U.S. developer of a continuous glucose monitoring (CGM) system, have establishe...
Eurofins Discovery Launches Human Immune Models for COVID-19 New Therapeutic Discovery or Repurposing
2021-05-18 21:00
1597
ST. CHARLES, Mo., May 18, 2021 /PRNewswire/ -- Eurofins Discovery, the market leader in pharmacology services and drug discovery products with over forty years providing solutions for the pharmaceutical and biotech industry, announces the launch of new services in support of clients working to ad...
Firmenich Unveils Innovative Natural Solution to Recreate Meat-like Juiciness in Plant-based Alternatives
2021-05-18 20:00
1790
GENEVA, May 18, 2021 /PRNewswire/ -- Firmenich, the world's largest privately owned fragrance and taste company, is proud to announce the launch of Dynarome® SR, its proprietary, natural, Sustained Release technology designed to deliver an even more authentic meat experience in plant-based analog...
Nanoform's final clinical results confirm value proposition to the pharma industry
2021-05-18 13:48
1128
HELSINKI, Finland, May 18, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform "), an innovative nanoparticle medicine enabling company, today announced the completion and final results of its clinical study. The primary, secondary and optional exploratory objectives of the study were all met. Th...
Clover Announces Positive Preclinical Data for Second-Generation Protein-Based COVID-19 Vaccine Candidate Demonstrating Broad Neutralization Against Variants of Concern
2021-05-18 11:50
2312
* The publication is available as a pre-print on bioRxiv * Preclinical data demonstrates that a modified B.1.351 S-Trimer vaccine candidate induces broad neutralization against both the original SARS-CoV-2 strain and variants of concern (VoC) including the South African variant * A single bo...
Mycenax becomes Taiwan's first CDMO company to complete the CHO-S and CHOZN GS Cell Line Development with the Beacon(R) Optofluidic System
2021-05-18 10:32
12766
TAIPEI, May 18, 2021 /PRNewswire/ -- Mycenax (TWSE: 4726) becomes one of the first CDMO companies inAsia to adapt the Beacon Optofluidic system to cell line development services. Mycenax adopted Beacon® Optofluidic System, a high throughput selection system for single-cell cloning and quantifica...
Hummingbird Bioscience Raises US$125 Million in Series C Financing
2021-05-18 09:35
2281
* Investment round led by Novo Holdings, joined by a syndicate of international biotech investors * Proceeds will support advancement of Hummingbird's lead assets in clinical trials and building of its next-generation portfolio of precision therapeutics * Kenneth Harrison from Novo Ventures ...
JA Worldwide Inducts 2021 Laureates into the Global Business Hall of Fame
2021-05-18 04:46
1257
BOSTON, May 18, 2021 /PRNewswire/ -- The Global Business Hall of Fame, presented by JA Worldwide, features entrepreneurs and business leaders spanning the last two centuries. From the inventor of blue jeans to the co-founder of one of the world's leading biotech companies, visitors to the digital...
JA Worldwide Inducts 2021 Laureates into the Global Business Hall of Fame
2021-05-18 01:10
1389
BOSTON, May 17, 2021 /PRNewswire/ -- The Global Business Hall of Fame, presented by JA Worldwide, features entrepreneurs and business leaders spanning the last two centuries. From the inventor of blue jeans to the co-founder of one of the world's leading biotech companies, visitors to the digital...
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 317 media titles]
2024-05-07 08:00VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 312 media titles]
2024-05-08 14:37OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 306 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 290 media titles]
2024-05-08 16:44Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
14378
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
9999
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
9532